Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsDr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.
The Trump administration is considering appointing Houman Hemmati, an ophthalmologist and a frequent Fox News guest, to lead the FDA's Center for Biologics Evaluation and...
Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.
Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.
New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.
Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.
A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Cancer detection recovered following pandemic disruptions
3.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
4.
Three out of ten breast cancers detected between screenings, study finds
5.
Screening for prostate cancer: is it time to give up digital rectal examination?
1.
The Dark Side of Melanoma: Uncovering the Risk Factors and Prevention Strategies
2.
A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis
3.
Unveiling the Hidden Benefits of Lymphedema Treatment
4.
Cemiplimab: A Revolutionary Drug For Treating Cancer
5.
Hepatocellular Carcinoma: Progress in Detection, Pathogenesis, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
3.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
4.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge